Technical Chemicals' Rapid Test HIV overseas sales expected to begin this year.
This article was originally published in The Gray Sheet
Executive SummaryTECHNICAL CHEMICALS AND PRODUCTS' 10-MINUTE TCPI RAPID TEST HIV is expected to generate sales before the end of the year in overseas markets such as India and Africa, the company says. The test kit, which will sell for less than $10, is designed to be used as an on-site screening test for HIV-1 and HIV-2. It produces results within five to 10 minutes and requires less "specialized equipment or training" than enzyme immunoassay tests or Western blot confirmatory tests, Technical Chemicals says.
You may also be interested in...
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.
In 2019, Mylan moved up to become the world’s leading generics, biosimilars and OTC player, according to Informa Pharma Intelligence’s latest global rankings. Sandoz has surpassed troubled Teva into second place but is set to surrender that position following the sale of its US solid-dose and dermatology business to India’s Aurobindo.